Technical Analysis for VRCA - Verrica Pharmaceuticals Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Historical VRCA trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Volume Surge | Other | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| New Downtrend | Bearish | 8.90% | |
| Wide Bands | Range Expansion | 8.90% | |
| Down 3 Days in a Row | Weakness | 8.90% | |
| Down 4 Days in a Row | Weakness | 8.90% | |
| Oversold Stochastic | Weakness | 8.90% | |
| Wide Bands | Range Expansion | 8.41% | |
| Down 3 Days in a Row | Weakness | 8.41% |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 09/27/2019
- Sector: Healthcare
- Industry: Biotechnology
Verrica is a pharmaceutical company focused on identifying, developing and commercializing innovative pharmaceutical products for the treatment of skin diseases with significant unmet needs. The company’s lead product candidate, VP-102, is currently being evaluated in two Phase 3 clinical trials for the treatment of molluscum and in a Phase 2 clinical trial for the treatment of common warts.
Health Pharmaceutical Pharmaceutical Industry Medication Pharmaceutical Products Clinical Trial Skin Diseases Common Warts Treatment Of Skin Diseases
Health Pharmaceutical Pharmaceutical Industry Medication Pharmaceutical Products Clinical Trial Skin Diseases Common Warts Treatment Of Skin Diseases
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 18.67 |
| 52 Week Low | 6.79 |
| Average Volume | 77,806 |
| 200-Day Moving Average | 13.05 |
| 50-Day Moving Average | 11.56 |
| 20-Day Moving Average | 11.91 |
| 10-Day Moving Average | 10.65 |
| Average True Range | 1.28 |
| ADX | 24.99 |
| +DI | 19.14 |
| -DI | 29.05 |
| Chandelier Exit (Long, 3 ATRs ) | 12.15 |
| Chandelier Exit (Short, 3 ATRs ) | 12.14 |
| Upper Bollinger Band | 15.99 |
| Lower Bollinger Band | 7.82 |
| Percent B (%b) | 0.21 |
| BandWidth | 68.63 |
| MACD Line | -0.76 |
| MACD Signal Line | -0.25 |
| MACD Histogram | -0.5065 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 10.94 | ||||
| Resistance 3 (R3) | 10.91 | 10.42 | 10.70 | ||
| Resistance 2 (R2) | 10.42 | 10.06 | 10.43 | 10.62 | |
| Resistance 1 (R1) | 9.98 | 9.85 | 10.20 | 10.01 | 10.55 |
| Pivot Point | 9.49 | 9.49 | 9.60 | 9.50 | 9.49 |
| Support 1 (S1) | 9.05 | 9.13 | 9.27 | 9.08 | 8.53 |
| Support 2 (S2) | 8.56 | 8.92 | 8.57 | 8.46 | |
| Support 3 (S3) | 8.12 | 8.56 | 8.38 | ||
| Support 4 (S4) | 8.15 |
